Portable CPAP Device Advances Sleep Therapy
By HospiMedica International staff writers Posted on 06 Jan 2015 |
A new continuous positive airway pressure (CPAP) device customizes therapy by monitoring pressure requirements thousands of times per night.
The Z1 Auto CPAP automatically responds to changes in breathing patterns and delivers maximum comfort by using the lowest possible therapy pressure throughout the sleep cycle. The proprietary breathing algorithm and sampling rate of several times per second assures extremely responsive and effective therapy at lower overall pressures than fixed-pressure CPAP devices, resulting in a more responsive therapy, a natural breathing pattern, and a more comfortable experience.
Proprietary integrated PowerShell technology and an overnight lithium-ion battery module provide enhanced portability, as together they serve as a surrogate power supply for built-in charging using the standard Z1 power adapter. A soft, padded neoprene skin which covers a solid plastic skeleton ensures that the Z1 Auto is securely fitted into the PowerShell. A heat/moisture exchanger (HME), custom tube adaptors, and other accessories are available for a variety of masks.
The device can also be paired with the Nitelog Apple iOS app, which syncs upon command to display immediate and complete therapy results, including apnea/hypopnea index and count, usage hours, and pressure. The results are available in day-week-month presentations and may be shared with a healthcare provider or physician by e-mail. The Z1 Auto CPAP is a product of Human Design Medical (HDM; Allston, MA, USA), and has been approved by the US Food and Drug Administration (FDA).
“The Z1 Auto alone is a giant leap forward in CPAP technology and portability, and coupling it with Nitelog has created a CPAP user's best friend,” said Steve Moore, senior vice president of sales and marketing at HDM. “Now users can sync their device with their phone to monitor their sleep data as their first activity upon awakening. This truly is an exciting advancement for a sleep therapy device that was designed with the user in mind.”
Related Links:
Human Design Medical
The Z1 Auto CPAP automatically responds to changes in breathing patterns and delivers maximum comfort by using the lowest possible therapy pressure throughout the sleep cycle. The proprietary breathing algorithm and sampling rate of several times per second assures extremely responsive and effective therapy at lower overall pressures than fixed-pressure CPAP devices, resulting in a more responsive therapy, a natural breathing pattern, and a more comfortable experience.
Proprietary integrated PowerShell technology and an overnight lithium-ion battery module provide enhanced portability, as together they serve as a surrogate power supply for built-in charging using the standard Z1 power adapter. A soft, padded neoprene skin which covers a solid plastic skeleton ensures that the Z1 Auto is securely fitted into the PowerShell. A heat/moisture exchanger (HME), custom tube adaptors, and other accessories are available for a variety of masks.
The device can also be paired with the Nitelog Apple iOS app, which syncs upon command to display immediate and complete therapy results, including apnea/hypopnea index and count, usage hours, and pressure. The results are available in day-week-month presentations and may be shared with a healthcare provider or physician by e-mail. The Z1 Auto CPAP is a product of Human Design Medical (HDM; Allston, MA, USA), and has been approved by the US Food and Drug Administration (FDA).
“The Z1 Auto alone is a giant leap forward in CPAP technology and portability, and coupling it with Nitelog has created a CPAP user's best friend,” said Steve Moore, senior vice president of sales and marketing at HDM. “Now users can sync their device with their phone to monitor their sleep data as their first activity upon awakening. This truly is an exciting advancement for a sleep therapy device that was designed with the user in mind.”
Related Links:
Human Design Medical
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Read the full article by registering today, it's FREE!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
- Free digital version edition of HospiMedica International sent by email on regular basis
- Free print version of HospiMedica International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of HospiMedica International in digital format
- Free HospiMedica International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!
Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest Critical Care News
- Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients
- Peptide-Based Hydrogels Repair Damaged Organs and Tissues On-The-Spot
- One-Hour Endoscopic Procedure Could Eliminate Need for Insulin for Type 2 Diabetes
- AI Can Prioritize Emergecny Department Patients Requiring Urgent Treatment
- AI to Improve Diagnosis of Atrial Fibrillation
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure